Skip to main content
Journal of Virology logoLink to Journal of Virology
. 2009 Dec 16;84(5):2623–2628. doi: 10.1128/JVI.02142-09

Stability of Murine Cytomegalovirus Genome after In Vitro and In Vivo Passage

Tammy P Cheng 1, Mark C Valentine 2, Jian Gao 1, Jeanette T Pingel 2, Wayne M Yokoyama 1,2,*
PMCID: PMC2820925  PMID: 20015993

Abstract

While large DNA viruses are thought to have low mutation rates, only a small fraction of their genomes have been analyzed at the single-nucleotide level. Here, we defined the genetic stability of murine cytomegalovirus (MCMV) by whole-genome sequencing. Independently assembled sequences of three sister plaques showed only two single-base-pair substitutions after in vitro passage. In vivo-passaged MCMV likewise demonstrated low mutation rates, comparable to those after in vitro passage, indicating high genome stability of MCMV at the single-nucleotide level in the absence of obvious selection pressure.


Large DNA viruses, such as herpesviruses, are thought to have low mutation rates as estimated by methods such as analysis of restriction fragment length polymorphisms or function of individual genes (10, 16). However, these analyses sample only a small fraction of the genome (11, 15). Moreover, in the presence of selective pressure, mutations have been identified in both human and murine cytomegalovirus (HCMV and MCMV, respectively) (5, 7, 17). For example, in HCMV, mutations in UL97 account for ganciclovir (GCV) resistance in up to 25% of immunosuppressed patients infected with HCMV (12, 18). However, whether these resistant mutant strains arise de novo or represent new infection is impossible to ascertain in the clinical setting.

Previous studies demonstrated that after in vivo passage, MCMV does acquire de novo mutations. Mutants emerge after passage through mice lacking adaptive immunity but carrying the Cmv1r allele, which encodes the Ly49H activation receptor on NK cells (7, 19). The only known ligand for Ly49H is MCMV-encoded open reading frame (ORF) m157. In mice infected with a plaque-purified MCMV clone containing intact m157, all escape viruses had m157 mutations. These mutants carried either single-amino-acid substitutions or premature stop codons and demonstrated increased virulence in naïve Cmv1r mice (8). In contrast, there were no mutations in the adjacent ORFs, m156 and m158. Taken together, these data indicate that mutations occur in both HCMV and MCMV under selective pressure. However, absent this pressure, their genomewide stability has not been determined at the single-nucleotide level.

In the current study, we set out to detail MCMV genomewide sequence changes after in vitro and in vivo passages in the absence of obvious selection pressure. To determine MCMV genome stability in vitro, we subcloned our laboratory stock of Smith strain MCMV (a gift from Herbert Virgin, Washington University, St. Louis, MO) that had been previously passaged in vivo. Our stock was plaque purified twice on NIH-3T12 monolayers. At the second round of plaque purification, three sister plaques were selected and independently amplified in vitro by sequential passages for 21 days in NIH-3T12 cells. Virions were then isolated from the culture medium, and genomic DNA was extracted for shotgun sequencing by the Sanger method. Using the bioinformatics software package Phred/Phrap/Consed (9), we then independently assembled complete genomic sequences of these clones, named MCMV-WT1, -WT2, and -WT3, with an average of 8-fold coverage per genome. Moreover, we subsequently validated these sequences (see below). Interestingly, the sequences from MCMV-WT1 and -WT2 were identical, whereas MCMV-WT3 differed at only two base pairs (bp): a G→A change at residue 8847 and an A→G change at residue 227424. The first change results in a synonymous mutation in putative ORF m09, while the second change does not fall into any known or predicted ORF. Assuming that these mutations do not affect viral growth, we estimated the mutation rate for MCMV after in vitro passage to be ∼1.4 × 10−7 mutations per bp per day (2 mutations in 3 genomes at 230,379 bp per genome per 21 days). Thus, the MCMV genome is highly stable at the single-nucleotide level during multiple rounds of in vitro passage.

In contrast to the near identity between the sister plaques, our laboratory's Smith strain MCMV differed from the previously published Smith strain (NCBI accession number U68299) (14) (Fig. 1 and Table 1). There were 452 differences, including 50 insertion/deletions (indels) and 402 single-bp substitutions. While some of these differences could represent sequencing errors in the original Rawlinson sequence, we visualized the differences between MCMV-WT1 and the Rawlinson sequence in nonoverlapping 100-bp windows across the genome (Fig. 1). Whereas the majority of differences fell into the central coding region, the single window containing the most differences occurred in ORF m04, which encodes an m02 glycoprotein family member. To determine how these differences affected ORFs, we also identified all ORFs previously described (1, 14) (Table 1). Specifically, previously annotated ORFs were located in MCMV-WT1 via a Perl script, which, for each ORF, first searched for an exact match of the entire ORF. If no identical sequence was found, then the script searched for 10-nucleotide sequences which matched the beginning and end of the known ORF and were separated by the expected distance. If no matches were found, the existing ORFs were aligned to a large region of MCMV-WT1 to find the region of greatest similarity. Because of the large number of indels between MCMV-WT1 and Rawlinson's annotation, we adjusted the ORF ends for MCMV-WT1 by examining the protein translations of all ORFs and annotating the ends accordingly. Although most ORFs showed comparable protein lengths, the large number of differences between the Rawlinson sequence and our MCMV-WT1 made it impossible to attribute any changes in viral function to specific nucleotide changes. Regardless, this high number of differences suggested that MCMV mutated in vivo, as we had previously maintained our MCMV stock by in vivo passages.

FIG. 1.

FIG. 1.

Genomic differences between MCMV-WT1 and Smith strain MCMV sequenced by Rawlinson and colleagues. Differences between MCMV-WT1 and the Rawlinson sequence are summed in 100-bp, nonoverlapping intervals along the genomic position.

TABLE 1.

Predicted ORFs in MCMV-WT1 compared to those in the previously published sequence

ORF Stranda MCMV-WT1
Rawlinson's MCMV sequenceb
No. of differencesc
Start End ORF length Start End ORF length
m01 C 468 870 402 480 836 356 1
m02 1033 2013 980 999 1979 980
m03 2270 3109 839 2236 3102 866 15
m04 3267 4063 796 3270 4070 800 74
m05 4179 5200 1,021 4185 5210 1,025 31
m06 5291 6336 1,045 5300 6337 1,037 3
m07 6463 7407 944 6463 7407 944
m08 7459 8529 1,070 7459 8529 1,070
m09 8632 9513 881 8632 9513 881
m10 9624 10499 875 9624 10499 875
m11 10715 11614 899 10715 11614 899
m12 11686 12504 818 11686 12504 818
m13 12599 13000 401 12599 13000 401
m14 13085 13990 905 13085 13990 905
m15 14085 15065 980 14085 15065 980
m16 15044 15676 632 15044 15676 632
m17 C 15749 16951 1,202 15749 16951 1,202
m18 C 17071 20193 3,122 17071 20193 3,122
m19 20338 20781 443 20338 20781 443
m20 C 20579 23044 2,465 20802 23045 2,243 1
m21 22644 23333 689 22645 23334 689
m22 23585 23899 314 23586 23900 314
M23 C 23777 24952 1,175 23778 24953 1,175
m23.1 24825 25160 335 24826 25161 335
M24 C 25147 26118 971 25148 26119 971
M25 26014 28812 2,798 26015 28813 2,798
m25.1 C 28997 30601 1,604 28998 30602 1,604
m25.2 C 28997 30280 1,283 28998 30281 1,283
m25.3 C 30244 31656 1,412 30245 31657 1,412
m25.4 C 30244 31215 971 30245 31216 971
M26 C 31346 31924 578 31347 31925 578
M27 C 32247 34295 2,048 32247 34295 2,048
M28 C 34486 35778 1,292 34486 35778 1,292
m29 35747 36475 728 35747 36730 983 1
m29.1 C 36030 36661 631 36109 36660 551 1
m30 36885 39071 2,186 36884 37729 845 1
M31 37281 39071 1,790 37279 38829 1,550 1
M31b 38777 39079 302 38775 39065 290 1
M32 C 39283 41439 2,156 39280 41436 2,156
M34 43086 45650 2,564 43083 45647 2,564
M35 45912 47471 1,559 45909 47468 1,559
M37 C 49444 50481 1,037 49441 50478 1,037
M38 C 50465 51958 1,493 50462 51955 1,493
m38.5c C 51783 52523 740 51780 52520 740
m39 C 52487 53203 716 52484 53200 716
m40 C 53268 53633 365 53265 53630 365
m41 C 53786 54202 416 53783 54199 416
m42 C 54355 54846 491 54352 54843 491
M43 C 55354 57147 1,793 55351 57144 1,793
M44 C 57888 59123 1,235 57885 59120 1,235
m44.1 58759 60108 1,349 58756 60105 1,349
m44.3 59144 59428 284 59141 59425 284
M45e1 C 59518 62160 2,642 59515 62145 2,630 1
M45e2 C 62773 62880 107 62769 62876 107
m45.1 C 59520 63042 3,522 61764 63038 1,274 1
m45.2 62810 62890 80 62806 62886 80
M46 C 63044 63928 884 63040 63924 884
m48.1 73566 73877 311 73562 73873 311
m48.2 C 73575 73871 296 73571 73867 296
M49 C 73923 75533 1,610 73919 75529 1,610 1
M50 C 75505 76455 950 75501 76451 950 5
M51 C 76519 77220 701 76515 77216 701 1
M52 76919 78471 1,552 76915 78468 1,553 2
M53 78465 79462 997 78461 79462 1,001 3
M55 C 83004 85811 2,807 83003 85816 2,813 61
M56 C 85711 88107 2,396 85716 88112 2,396 1
m58 91756 92459 703 91761 92465 704 8
m59 93236 94393 1,157 93241 94263 1,022 5
M69 C 96284 98812 2,528 96193 98721 2,528
m69.1 98621 98979 358 98530 98889 359 1
M70 C 99101 101995 2,894 99010 101904 2,894 2
M71 101994 102893 899 101903 102802 899
M72 C 103122 104327 1,205 103031 104236 1,205 5
M73 104191 104609 418 104100 104519 419 8
M73.5e2 105888 106160 272 105797 106069 272
m74 C 104587 105903 1,316 104496 105812 1,316 19
M75 C 106205 108382 2,177 106110 108287 2,177 30
M76 108479 109242 763 108384 109148 764 2
M77 109026 110912 1,886 108931 110817 1,886
M78 111084 112498 1,414 110989 112404 1,415 4
M79 C 112737 113513 776 112639 113415 776 2
M80 113512 115607 2,095 113414 115507 2,093 11
M82 C 115812 117611 1,799 115711 117507 1,796 6
M83 C 117718 120147 2,429 117614 120043 2,429 13
M84 C 120186 121949 1,763 120082 121845 1,763 10
M85 C 122293 123228 935 122189 123124 935 1
M87 127487 130267 2,780 127383 130163 2,780
M88 130347 131626 1,279 130243 131523 1,280 2
m90 C 133020 133976 956 132920 133876 956
M91 133768 134172 404 133668 134072 404
M92 134175 134867 692 134075 134767 692
M93 134833 136379 1,546 134733 136280 1,547 1
M94 136334 137370 1,036 136234 137271 1,037 11
M89Ex1 C 137487 138380 893 137390 138283 893 1
M95 138379 139632 1,253 138282 139535 1,253
M96 139632 140021 389 139535 139924 389
M97 140238 142168 1,930 140141 142072 1,931 1
M98 142198 143883 1,685 142101 143786 1,685
M99 143820 144158 338 143723 144061 338
M100 C 144393 145508 1,115 144296 145411 1,115
M102 145693 148131 2,438 145596 148034 2,438
M103 C 148279 149232 953 148182 149135 953
M104 C 149210 151324 2,114 149113 151227 2,114
M105 151125 153971 2,846 151028 153874 2,846
m106 C 154010 154453 443 153913 154356 443
m106.1 C 154293 154553 260 154196 154456 260
m106.3 C 155878 156015 137 155781 155918 137
m107 162083 162777 694 161983 162678 695 2
m108 C 162310 162870 560 162210 162770 560
M114 C 165696 166484 788 165596 166384 788
M115 C 166484 167308 824 166384 167208 824
M116 C 167305 169242 1,937 167205 169142 1,937
m117 C 169313 171010 1,697 169213 170910 1,697
m117.1 169641 171055 1,414 169541 170956 1,415 1
M118 C 171080 172045 965 170980 171945 965
m119.1 C 172156 173091 935 172056 172991 935
m119.2 C 173122 173490 368 173022 173390 368
m119.3 C 173510 173821 311 173410 173721 311
m119.4 C 174154 174435 281 174054 174335 281
m119.5 174254 174589 335 174154 174489 335
m120 C 174399 174674 275 174299 174574 275
m120.1 C 174740 175825 1,085 174640 175725 1,085
M121 C 175779 177875 2,096 175679 177775 2,096
M121 C 175779 177875 2,096 175679 177775 2,096
m123.1 C 181963 182319 356 181863 182219 356
m123Ex2 C 181756 181866 110 181656 181766 110
m124 182033 182380 347 181933 182280 347
m124.1 C 182111 182518 407 182011 182418 407
m125 183536 183865 329 183436 183765 329
m126 184635 184910 275 184535 184810 275
m127 C 185290 185691 401 185190 185591 401
m128Ex3 186185 187399 1,214 186085 187299 1,214
m129 C 187447 187947 500 187347 187847 500
m130 187907 188380 473 187807 188280 473
m131 C 188126 188476 350 188026 188376 350
m133Ex1 C 188978 189895 917 188878 189795 917
m134 189968 190381 413 189868 190281 413
m135 C 189995 190321 326 189895 190221 326
m136 C 190410 191171 761 190310 191071 761
m137 C 191188 192192 1,004 191088 192092 1,004
m138 C 192333 194042 1,709 192233 193942 1,709
m139 C 194182 196116 1,934 194082 196016 1,934
m140 C 196162 197616 1,454 196062 197516 1,454
m141 C 197805 199331 1,526 197705 199231 1,526
m142 C 199541 200848 1,307 199441 200748 1,307
m143 C 201065 202694 1,629 200920 202593 1,673 1
m144 C 202843 203994 1,151 202742 203893 1,151
m145 C 204130 205593 1,463 204029 205492 1,463
m146 C 205743 206876 1,133 205642 206775 1,133
m147 C 206963 207400 437 206862 207299 437
m148 207029 207388 359 206928 207287 359
m149 207427 208116 689 207326 208015 689
m150 C 207724 208890 1,166 207623 208789 1,166
m151 C 208915 210084 1,169 208814 209983 1,169
m152 C 210342 211478 1,136 210241 211377 1,136
m153 C 211688 212905 1,217 211587 212804 1,217
m154 C 213043 214149 1,106 212942 214048 1,106
m155 C 214535 215668 1,133 214434 215567 1,133
m156 C 215635 216078 443 215534 215977 443
m157 C 215996 216985 989 215895 216884 989
m158 C 217033 218103 1,070 216932 218002 1,070
m159 C 218271 219467 1,196 218170 219366 1,196
m160 C 219699 220625 926 219598 220524 926
m161 C 220573 221250 677 220472 221149 677
m162 C 221287 221766 479 221186 221665 479
m163 C 221976 222515 539 221875 222414 539
m164 C 222467 223750 1,283 222366 223649 1,283
m165 C 223381 224379 998 223280 224278 998
m166 C 224514 225662 1,148 224413 225561 1,148
m167 C 225880 227190 1,310 225779 227089 1,310
m168 228021 228566 545 227920 228465 545
m169 C 228411 228809 398 228310 228708 398
m170 C 229440 230147 707 229339 230046 707
a

“C” denotes an ORF on the negative strand, while the absence of remarks in the strand column denotes the positive strand.

b

NCBI accession number U68299.

c

Differences between MCMV-WT1 and Rawlinsons's MCMV sequence, as determined by the Crossmatch algorithm in Consed, were enumerated in each predicted ORF (9). They do not precisely correspond to the data shown in Fig. 1, which displays the number of differences in each 100-bp, nonoverlapping window.

To elucidate genome stability after in vivo passage, we infected 4-week-old BALB/c mice with MCMV-WT1 and prepared a bulk viral stock from salivary glands 14 days later. Subsequently, we extracted genomic DNA and ligated DNA fragments of this potentially heterogeneous viral stock into shotgun library vectors for sequencing. With a total of 12,642 sequences by the Sanger method, equivalent to 28-fold coverage of the MCMV genome, we found that the bulk salivary stock and the input MCMV-WT1 sequence shared an identical genomic consensus sequence. However, when we used Consed navigator to highlight differences at the individual shotgun library clone level, we identified 12 differences with a Phrap quality value of 40 or greater (Table 2). Several of these differences were identified in both forward and reverse directions, ruling out differences as sequencing errors. These mutations were located randomly throughout the genome, with the possible exception of m159, which contained three mutations, suggesting in vivo selection. There were no mutations in m157, consistent with the absence of Ly49h in BALB/c mice. Excluding the three mutations in m159, the remaining 9 mutations allowed us to estimate the mutation rate of MCMV as ∼1.0 × 10−7 mutations per bp per day after in vivo passage, very similar to the mutation rate calculated for in vitro passage.

TABLE 2.

Subpopulation differences in salivary gland stock from BALB/c mice after in vivo passagea

Residue ORF Difference from consensus Amino acid change No. of shotgun library reads with:
Mutant fraction (%)
Mutation Consensus residue
135 None G→A NA 1 70 1.4
190 None G→C NA 1 69 1.4
77068 M52 G→A Synonymous 1 31 3.1
143110 M98 G→T Synonymous 1 32 3.0
143111 M98 C→G Leu→Val 1 32 3.0
162252 m107 C→T Arg→Lys 2 35 5.4
162328 m108 A→C Phe→Val 1 41 2.4
219363 m159 C→T Glu→Lys 2 54 3.6
219365 m159 C→T Gly→Lys 2 54 3.6
219366 m159 C→T Gly→Lys 2 54 3.6
230248 None C→T NA 1 41 2.4
230287 None C→T NA 1 41 2.4
a

The corresponding ORF, if previously annotated, is listed, along with the amino acid change, if relevant. To determine the fraction of shotgun clones with the indicated mutation, the number of shotgun clone reads with the indicated mutation are shown along with the corresponding number of shotgun clones with the consensus sequence. The mutant fraction is the number of mutant reads/number of consensus reads × 100. NA, not applicable.

To analyze in vivo mutation in a different system, we used B6.BXD8/RAG1KO, a novel murine strain deficient in both adaptive immunity and Ly49h on a C57BL/6 genetic background (3). Since m157 mutations occurred as a result of Ly49H immune selection, we hypothesized that no mutations would occur in m157 in the absence of Ly49H expression. We infected 8-week-old B6.BXD8/RAG1KO mice with MCMV-WT1 and harvested spleens 19 to 22 days later. Splenic isolates were plaque purified three times on NIH-3T12 monolayers and then amplified in vitro for 10 to 14 days for genomic DNA extraction. Pyrosequencing reads of each plaque-purified splenic isolate, aligned against the MCMV-WT1 sequence, covered more than 99% of the genomic sequence. Sequence analysis of two independent clones showed that one isolate maintained a sequence identical to MCMV-WT1, while the other isolate differed from MCMV-WT1 at a single residue, a C→A change at residue 52083. This change resulted in a synonymous mutation in predicted ORF m38.5. Moreover, neither splenic isolate demonstrated m157 mutations, contrasting with our previous finding that 100% of splenic isolates contained mutations in m157 after passage of an MCMV clone with an intact m157 through B6.SCID mice. Furthermore, we PCR amplified an 1,100-bp segment spanning ORF m157 in four other splenic isolates from B6.BXD8/RAG1KO mice. Sequencing of these amplicons revealed only the wild-type sequence (data not shown). Finally, these clones demonstrated no change in virulence compared to that of MCMV-WT1, as measured by splenic viral titers four days postinfection (data not shown). These findings are consistent with our hypothesis that host immune control via Ly49H favored viruses with selective mutations in m157. Moreover, we further confirmed the genomic stability of MCMV after in vivo passage.

Here, we examined genomic sequences of Smith strain MCMV and found high genome stability after short-term in vitro and in vivo passages. Whereas previous studies assessed only a small fraction of the genome, we characterized whole-genome sequences via both Sanger method and pyrosequencing. With two independent approaches, we resolved MCMV genomic sequences at the single-nucleotide level. After both in vitro and in vivo passages, we found that Smith strain MCMV-WT1 did not acquire functionally significant mutations at a high rate. One caveat to our mutation analysis is that lethal mutations were probably underrepresented in the final DNA pool since, by definition, they did not propagate. Nonetheless, this limitation is intrinsic to all mutation analysis. Lastly, the genomic stability of our MCMV clone could be due to prior, unintentional laboratory selection of MCMV that resulted in a genetically stable virus. Overall, our findings of extremely low mutation rates in vitro and in vivo are consistent with the hypothesis that in the absence of selective pressure, MCMV demonstrates a low mutation rate, comparable to those of other DNA-based microbes (6).

Interestingly, previous epidemiologic studies on another herpesvirus family member, human herpesvirus (HSV), delineated ORFs in the Us region as more divergent between HSV-1 and HSV-2, suggesting that mutations preferentially occurred in this area (2). While gene location has been thought to play a role in genome stability (2, 4, 13), in light of our current and previous studies of m157 mutations, the higher gene divergence may reflect differences in viral pathogenesis. Specifically, in our current study, MCMV did not appear to preferentially accumulate mutations in specific loci (except for, possibly, m159) in the absence of obvious selective pressure. In other words, an alternative hypothesis for the finding of mutations concentrating in certain loci is that they reflect host selective pressure, as seen in the setting of B6 mice which possess Cmv1r (Ly49h).

Nucleotide sequence accession number.

The GenBank accession number for MCMV-WT1 is GU305914.

Acknowledgments

This work was supported by an Abbott Scholars Award to T.P.C. and by NIH grant RO1-AI51345 to W.M.Y., who is a Howard Hughes Medical Institute investigator.

Footnotes

Published ahead of print on 16 December 2009.

REFERENCES

  • 1.Brocchieri, L., T. N. Kledal, S. Karlin, and E. S. Mocarski. 2005. Predicting coding potential from genome sequence: application to betaherpesviruses infecting rats and mice. J. Virol. 79:7570-7596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Brown, J. 2004. Effect of gene location on the evolutionary rate of amino acid substitutions in herpes simplex virus proteins. Virology 330:209-220. [DOI] [PubMed] [Google Scholar]
  • 3.Cheng, T. P., A. R. French, B. F. Plougastel, J. T. Pingel, M. M. Orihuela, M. L. Buller, and W. M. Yokoyama. 2008. Ly49h is necessary for genetic resistance to murine cytomegalovirus. Immunogenetics 60:565-573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Choi, J. K., B. S. Lee, S. N. Shim, M. Li, and J. U. Jung. 2000. Identification of the novel K15 gene at the rightmost end of the Kaposi's sarcoma-associated herpesvirus genome. J. Virol. 74:436-446. [PMC free article] [PubMed] [Google Scholar]
  • 5.Chou, S., N. S. Lurain, A. Weinberg, G.-Y. Cai, P. L. Sharma, C. S. Crumpacker, and Adult AIDS Clinical Trials Group CMV Laboratories. 1999. Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Antimicrob. Agents Chemother. 43:1500-1502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Drake, J. W. 1991. A constant rate of spontaneous mutation in DNA-based microbes. Proc. Natl. Acad. Sci. U. S. A. 88:7160-7164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.French, A. R., J. T. Pingel, S. Kim, L. Yang, and W. M. Yokoyama. 2005. Rapid emergence of escape mutants following infection with murine cytomegalovirus in immunodeficient mice. Clin. Immunol. 115:61-69. [DOI] [PubMed] [Google Scholar]
  • 8.French, A. R., J. T. Pingel, M. Wagner, I. Bubic, L. Yang, S. Kim, U. Koszinowski, S. Jonjic, and W. M. Yokoyama. 2004. Escape of mutant double-stranded DNA virus from innate immune control. Immunity 20:747-756. [DOI] [PubMed] [Google Scholar]
  • 9.Gordon, D., C. Abajian, and P. Green. 1998. Consed: a graphical tool for sequence finishing. Genome Res. 8:195-202. [DOI] [PubMed] [Google Scholar]
  • 10.Hall, J. D., D. M. Coen, B. L. Fisher, M. Weisslitz, S. Randall, R. E. Almy, P. T. Gelep, and P. A. Schaffer. 1984. Generation of genetic diversity in herpes simplex virus: an antimutator phenotype maps to the DNA polymerase locus. Virology 132:26-37. [DOI] [PubMed] [Google Scholar]
  • 11.Karlin, S., E. S. Mocarski, and G. A. Schachtel. 1994. Molecular evolution of herpesviruses: genomic and protein sequence comparisons. J. Virol. 68:1886-1902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Martin, B. K., M. O. Ricks, M. S. Forman, and D. A. Jabs. 2007. Change over time in incidence of ganciclovir resistance in patients with cytomegalovirus retinitis. Clin. Infect. Dis. 44:1001-1008. [DOI] [PubMed] [Google Scholar]
  • 13.McGeoch, D. J., and A. J. Davison. 1999. The descent of human herpesvirus 8. Semin. Cancer Biol. 9:201-209. [DOI] [PubMed] [Google Scholar]
  • 14.Rawlinson, W. D., H. E. Farrell, and B. G. Barrell. 1996. Analysis of the complete DNA sequence of murine cytomegalovirus. J. Virol. 70:8833-8849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Rojas, J. M., J. Dopazo, E. Martin-Blanco, C. Lopez-Galindez, and E. Tabares. 1993. Analysis of genetic variability of populations of herpes simplex viruses. Virus Res. 28:249-261. [DOI] [PubMed] [Google Scholar]
  • 16.Sakaoka, H., K. Kurita, Y. Iida, S. Takada, K. Umene, Y. T. Kim, C. S. Ren, and A. J. Nahmias. 1994. Quantitative analysis of genomic polymorphism of herpes simplex virus type 1 strains from six countries: studies of molecular evolution and molecular epidemiology of the virus. J. Gen. Virol. 75(Pt. 3):513-527. [DOI] [PubMed] [Google Scholar]
  • 17.Sanchez Puch, S., C. Ochoa, G. Carballal, C. Zala, P. Cahn, R. Brunet, H. Salomon, and C. Videla. 2004. Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina. J. Clin. Virol. 30:271-275. [DOI] [PubMed] [Google Scholar]
  • 18.Stanat, S. C., J. E. Reardon, A. Erice, M. C. Jordan, W. L. Drew, and K. K. Biron. 1991. Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir. Antimicrob. Agents Chemother. 35:2191-2197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Voigt, V., C. A. Forbes, J. N. Tonkin, M. A. Degli-Esposti, H. R. Smith, W. M. Yokoyama, and A. A. Scalzo. 2003. Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proc. Natl. Acad. Sci. U. S. A. 100:13483-13488. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES